Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,239 | 377 | 99.5% |
| Education | $34.19 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,024 | 65 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $571.86 | 40 | $0 (2021) |
| Novo Nordisk Inc | $423.66 | 24 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $412.06 | 22 | $0 (2021) |
| Lilly USA, LLC | $407.71 | 21 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $388.88 | 26 | $0 (2021) |
| PFIZER INC. | $378.20 | 27 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $358.11 | 28 | $0 (2021) |
| Astellas Pharma US Inc | $288.78 | 15 | $0 (2021) |
| Amgen Inc. | $264.67 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.28 | 2 | Antares Pharma, Inc. ($61.28) |
| 2023 | $50.31 | 2 | Boston Scientific Corporation ($26.93) |
| 2021 | $959.55 | 53 | Lilly USA, LLC ($152.83) |
| 2020 | $1,271 | 76 | AstraZeneca Pharmaceuticals LP ($204.62) |
| 2019 | $1,179 | 74 | Boehringer Ingelheim Pharmaceuticals, Inc. ($325.61) |
| 2018 | $1,110 | 67 | PFIZER INC. ($219.16) |
| 2017 | $1,643 | 109 | Boehringer Ingelheim Pharmaceuticals, Inc. ($285.59) |
All Payment Transactions
383 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/28/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/23/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 07/13/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 07/09/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: Neurology | ||||||
| 07/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiovascular | ||||||
| 06/25/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 06/24/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/08/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Sleep | ||||||
| 06/04/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: UROLOGY | ||||||
| 06/01/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 05/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Sleep | ||||||
| 05/07/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 380 | $90,350 | $28,983 |
| 2022 | 7 | 314 | 420 | $97,955 | $30,314 |
| 2021 | 8 | 361 | 485 | $84,195 | $40,141 |
| 2020 | 11 | 530 | 674 | $70,823 | $43,318 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 120 | $36,680 | $11,711 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 139 | $30,050 | $9,111 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $18,945 | $5,827 | 30.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,250 | $1,176 | 94.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,560 | $780.00 | 50.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 24 | $870.00 | $228.48 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $995.00 | $150.12 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 129 | $39,725 | $11,518 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 145 | $30,795 | $9,107 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $21,410 | $6,674 | 31.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 26 | $1,820 | $1,779 | 97.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 27 | $1,755 | $863.84 | 49.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 22 | $770.00 | $209.80 | 27.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 24 | $1,680 | $162.83 | 9.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 202 | $41,560 | $20,418 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $12,160 | $7,176 | 59.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 94 | $16,820 | $6,097 | 36.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 37 | 37 | $2,585 | $2,410 | 93.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $4,565 | $1,742 | 38.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 14 | 14 | $1,330 | $1,208 | 90.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 40 | $2,585 | $741.00 | 28.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 35 | 37 | $2,590 | $348.93 | 13.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 224 | $33,600 | $18,458 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 82 | 82 | $10,660 | $10,301 | 96.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 99 | $9,140 | $4,905 | 53.7% |
About Dr. Gidon Goldenberg, M.D
Dr. Gidon Goldenberg, M.D is a Internal Medicine healthcare provider based in North Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689619041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gidon Goldenberg, M.D has received a total of $6,274 in payments from pharmaceutical and medical device companies, with $61.28 received in 2024. These payments were reported across 383 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,239).
As a Medicare-enrolled provider, Goldenberg has provided services to 1,495 Medicare beneficiaries, totaling 1,959 services with total Medicare billing of $142,757. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location North Haven, CT
- Active Since 06/19/2006
- Last Updated 09/11/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689619041
Products in Payments
- JARDIANCE (Drug) $635.95
- FARXIGA (Drug) $345.55
- JANUVIA (Drug) $286.97
- XARELTO (Drug) $261.76
- Vascepa (Drug) $259.84
- SPIRIVA RESPIMAT (Drug) $251.96
- HETLIOZ (Drug) $235.48
- Ozempic (Drug) $216.55
- MYRBETRIQ (Drug) $205.54
- STIOLTO RESPIMAT (Drug) $194.94
- Hetlioz (Drug) $176.58
- VRAYLAR (Drug) $164.50
- TRULICITY (Drug) $158.86
- ENTRESTO (Drug) $157.36
- INVOKANA (Drug) $127.12
- UBRELVY (Drug) $122.78
- Prolia (Biological) $118.18
- TRADJENTA (Drug) $98.86
- LYRICA (Drug) $94.87
- EUCRISA (Drug) $94.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Haven
Dr. Lorenzo Galante, Md, MD
Internal Medicine — Payments: $30,892
Bjorn Ringstad, Md, MD
Internal Medicine — Payments: $4,225
Eric Liben, Md, MD
Internal Medicine — Payments: $3,652
Fausto Petruzziello, Md, MD
Internal Medicine — Payments: $3,443
Dr. Dianne Defusco, Md, MD
Internal Medicine — Payments: $2,258
Dr. Georgia Kelley, M.d, M.D
Internal Medicine — Payments: $1,535